BioSpace News Archive

Business

New-Generation Benchtop Mass Spectrometer Advances Quantitative Proteomics and Translational Research

Thermo Scientific Orbitrap Exploris 480 mass spectrometer designed for high-throughput biopharmaceutical and academic research laboratories

June 3, 2019
·
5 min read
Pharm Country

Relmada Therapeutics to Present at LD Micro Invitational Conference in Los Angeles

Company Presentation Scheduled for Wednesday June 5, 2019 at 11:40 a.m. Pacific Time.

June 3, 2019
·
3 min read
Medicinal Cannabis Investment Opportunity and Partnership with “Funcrops in Portugal”

A promising and emerging Portugal based cannabis company, Funcrops opened its doors for investors.

June 3, 2019
·
2 min read
Business

Mobidiag announces launch of Automobi Molecular Diagnostics

Joint venture between Mobidiag and Autobio Diagnostics will commercialise Novodiag® platform and selected infectious disease assays in the Greater China territory

June 3, 2019
·
4 min read
Biotech Beach

Urovant Sciences to Present at Annual Roivant Pipeline Day

Urovant Sciences announced Chief Executive Officer Keith A. Katkin will present at the annual Roivant Pipeline Day on June 6, 2019 at 1:50 p.m. ET.

June 3, 2019
·
2 min read
Drug Development

New Ad-hoc Analysis of Phase 3 HELP Study™ Evaluates Prevention of HAE Attacks with TAKHZYRO® (lanadelumab) During Early Treatment Phase

Data Presented at European Academy of Allergy and Clinical Immunology Congress

June 3, 2019
·
10 min read
Business

Astellas and Seattle Genetics Announce Antibody-Drug Conjugate Enfortumab Vedotin Produced Tumor Response Rate of 44 Percent in Patients with Most Common Type of Advanced Urothelial (Bladder) Cancer

Astellas Pharma Inc. and Seattle Genetics, Inc. announced that data from the first cohort of a pivotal phase 2 clinical trial known as EV-201 demonstrated that the investigational agent enfortumab vedotin rapidly shrank tumors in most patients, resulting in an objective response rate of 44 percent

June 3, 2019
·
11 min read
Business

Alpine Immune Sciences Appoints Biopharma Veteran Wayne Gombotz as Chief Technology Officer

Alpine Immune Sciences, Inc. announced the appointment of Wayne Gombotz, PhD as Chief Technology Officer.

June 3, 2019
·
2 min read
Biotech Bay

Intrexon Announces Advances in Non-Browning GreenVenus™ Romaine Lettuce

Non-Browning Romaine lettuce demonstrates improved shelf life, reducing food waste and is not subject to regulation as a product produced through genetic engineering by the USDA

June 3, 2019
·
3 min read
BioCapital

USP Publishes New and Revised Compounding Standards

Standards help ensure quality compounded preparations to safeguard the well-being of patients

June 3, 2019
·
4 min read